Holger Wesche
Chief Tech/Sci/R&D Officer at HARPOON THERAPEUTICS, INC.
Profile
Holger Wesche is currently the Chief Scientific Officer at Harpoon Therapeutics, Inc. He previously worked as a Scientific Director at Amgen, Inc. from 2013 to 2015.
He obtained a doctorate degree from the University of Hannover.
Holger Wesche active positions
Companies | Position | Start |
---|---|---|
HARPOON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-09-30 |
Former positions of Holger Wesche
Companies | Position | End |
---|---|---|
AMGEN INC. | Chief Tech/Sci/R&D Officer | 2015-03-31 |
Training of Holger Wesche
University of Hannover | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
AMGEN INC. | Health Technology |
Private companies | 1 |
---|---|
Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Holger Wesche